Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Loh NY. et al, (2020), Nat Commun, 11
Briant LJB. et al, (2018), J Physiol, 596, 197 - 215
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Mentz RJ. et al, (2017), Am Heart J, 187, 1 - 9
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Holman RR. et al, (2017), Lancet Diabetes Endocrinol, 5, 877 - 886
21 May 2020
The DTU is managing the UK sites for a global study testing if either chloroquine or hydroxychloroquine can prevent COVID-19 in vital frontline healthcare workers.
27 November 2019
Dr Nikolaos Nikolaou won the prize for the Best Metabolism and Obesity Oral Communication Prize at the 2019 British Endocrinology Society conference.
View previous and upcoming events in OCDEM.